PubMed · 16118555
Initial computed tomography imaging experience using a new macromolecular iodinated contrast medium in experimental breast cancer.
Abstract
OBJECTIVE: The objective of this study was to evaluate computed tomography (CT) enhancement characteristics for a new iodinated macromolecular contrast medium (MMCM), PEG12000-Gen4-triiodo, for angiographic effect and for assessment of abnormal vascular permeability in cancer. MATERIALS AND METHODS: Time persistence of angiographic effect was evaluated on rat CT images acquired over 30 minutes using the iodinated polyethyleneglycol- (PEG) based macromolecule. Dynamic CT imaging after PEG12000-Gen4-triiodo-enhancement in tumor-bearing rats was used to quantitatively estimate plasma volume and microvascular transendothelial permeability for both tumor and normal soft tissue. Using identical doses of iodine, 300 mg iodine/kg, blood curves for this MMCM and iohexol were compared. RESULTS: Serial whole-body CT angiograms using PEG12000-Gen4-triiodo showed diagnostic vascular detail through 20 minutes, and the blood enhancement curve was higher and more persistent than with small-molecular iohexol. Permeability estimates were significantly (P<0.02; paired t test) higher in tumors (48.2+/-18.1 microL/min-1 100 mL) than in muscle (2.5+/-5.7 microL/min-1 100 mL). CONCLUSIONS: Use of PEG-based MMCM for experimental CT allowed for a persistent angiographic enhancement and for quantitative estimation of tumor microvascular characteristics.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Gerhard H Simon, Yanjun Fu, Kirill Berejnoi, Laure S Fournier, Vincenzo Lucidi, Benjamin Yeh, David M Shames, Robert C Brasch. 2005. Initial computed tomography imaging experience using a new macromolecular iodinated contrast medium in experimental breast cancer.. https://doi.org/10.1097/01.rli.0000174477.11541.ce
Cite the original work for its findings. Save a collection to share your selection of sources.